In this regard, it is worth pointing out that ANGPTL3 levels are significantly higher in patients with advanced forms of NAFLD or nonalcoholic steatohepatitis (NASH), but no significant differences were detected in individuals with simple fatty liver (NAFL) when compared to healthy and normal weight individuals20. The gene discussed is ANGPTL3; the disease is metabolic dysfunction-associated steatotic liver disease.